Tag: INDIAN PHARMA NEWS
Himachal Pradesh’s Bulk Drug Park Gains Momentum with ₹1,000 Crore Central Support
The Union Government has sanctioned ₹1,000 crore in grant assistance for building shared infrastructure at the Bulk Drug Park coming up in Haroli, Unadistrict, Himachal Pradesh,...
D Mart Launches In-Store Pharmacies with Flat 20% Discount on Medicines
Avenue Supermarts Ltd., operator of India’s premier value-retail chain DMart, has officially expanded into the retail healthcare sector by launching pharmacy counters within select...
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
Lupin Limited announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA)...
WHO Introduces Shorter Treatment Options for Kala-azar and PKDL
World Health Organization has released a major revision of its clinical guidance for treating visceral leishmaniasis (commonly known as kala-azar) and post-kala-azar dermal leishmaniasis (PKDL), aiming to ease...
First-Ever Freeze-Dried Plasma Secures FDA Approval for Emergency Use in the U.S.
The U.S. Food and Drug Administration has granted its first-ever license for a freeze-dried plasma product, marking a major advance in emergency transfusion medicine....
FSSAI Suspends License of Dior Pharmaceuticals Over Critical Violations at Nutraceutical Manufacturing Unit
The Food Safety and Standards Authority of India (FSSAI) has officially suspended the manufacturing license of Dior Pharmaceuticals with immediate effect, following a comprehensive...
